Smith & Nephew plc (FRA:NPWA)

Market Cap	12.00B
Revenue (ttm)	5.07B
Net Income (ttm)	419.07M
Shares Out	n/a
EPS (ttm)	0.48
PE Ratio	28.63
Forward PE	15.19
Dividend	0.66 (2.28%)
Ex-Dividend Date	Oct 3, 2025

Volume	n/a
Average Volume	15
Open	28.80
Previous Close	29.00
Day's Range	28.80 - 28.80
52-Week Range	22.40 - 33.00
Beta	n/a
RSI	44.58
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,349
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NPWA

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD